-
Treatment and outcomes after on-treatment recurrent venous thromboembolism in patients with cancer: a post hoc analysis of the Hokusai venous thromboembolism cancer study
Lanting, V. R., van Bergen en Henegouwen, K., Bosch, F. T. M., Grosso, M. A., Segers, A., Raskob, G. E., Kamphuisen, T. P. W., Büller, H. R., Verhamme, P., Weitz, J. I., di Nisio, M., Carrier, M., van Es, N. & Wang, T.-F., Jul 2025, In: Journal of thrombosis and haemostasis. 23, 7, p. 2255-2261 7 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
Validation of clinical risk assessment scores for venous thromboembolism in patients with cancer: a population-based cohort study: Reply
Lanting, V., Vágó, E., Horváth-Puhó, E., Mulder, F., van Es, N. & Sørensen, H. T., 1 Jun 2025, In: Journal of thrombosis and haemostasis. 23, 6, p. 2071-2073 3 p.Research output: Contribution to journal › Comment/Letter to the editor* › Academic
-
The role of germline and somatic mutations in predicting cancer-associated thrombosis: a narrative review
Lanting, V., Oskam, M., Wilmink, H., Kamphuisen, P. W. & van Es, N., 1 May 2025, In: Current opinion in hematology. 32, 3, p. 138-145 8 p.Research output: Contribution to journal › Review article* › Academic › peer-review
- All publications